Post transplant repeated measurements of urine volume and serum creatinine (sCr) are used to assess kidney function. Under non-steady state conditions, repeated measurement of sCr allows calculation of the kinetic estimated GFR (KeGFR). Additional measurement of urinary creatinine allows the calculation of the creatinine excretion to (estimated) production ratio (E/eG). We hypothesized that post-transplant KeGFR and E/eG would predict delayed graft function (DGF), as early as 4 h and outperform a validated clinical model at 12 h. This was a retrospective analysis of prospectively acquired data in a study of 56 recipients of deceased-donor kidney transplant. We assessed predictive performance with the area under the receiver operator characteristic curve (AUC) and the added value to a clinical model with integrated discrimination improvement analysis. At 4 h, the AUC for E/eG was 0.87 (95% CI 0.77-0.96) and for KeGFR 0.69 (95% CI 0.56-0.83). Both E/eG and KeGFR improved the risk prediction of a clinical model for DGF by 32 and 18%, and for non-DGF by 17 and 10%, respectively. While E/eG had better predictive performance of DGF than KeGFR, KeGFR might also facilitate perioperative management including drug dosing after kidney transplantation. Together these measurements may facilitate the possibility of conducting trials of early intervention to ameliorate the adverse effects of ischaemia-reperfusion injury on long-term DGF.

Keywords:
GFR under non-steady state conditions, Delayed graft function, Kinetic eGFR, Creatinine excretion, Creatinine production
1.
Pianta TJ, Endre ZH, Pickering JW, Buckley NA, Peake PW: Kinetic estimation of GFR improves prediction of dialysis and recovery after kidney transplantation. PLoS One 2015;10:e0125669.
2.
Endre ZH, Pickering JW, Walker RJ: Clearance and beyond: the complementary roles of GFR measurement and injury biomarkers in acute kidney injury (AKI). Am J Physiol Renal Physiol 2011;301:F697-F707.
3.
Chew-Harris JS, Florkowski CM, Elmslie JL, Livesey J, Endre ZH, George PM: Lean mass modulates glomerular filtration rate in males of normal and extreme body composition. Intern Med J 2014;44:749-756.
4.
Chen S: Retooling the creatinine clearance equation to estimate kinetic GFR when the plasma creatinine is changing acutely. J Am Soc Nephrol 2013;24:877-888.
5.
Irish WD, Ilsley JN, Schnitzler MA, Feng S, Brennan DC: A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. Am J Transplant 2010;10:2279-2286.
6.
Pickering JW, Mellas J: A simple method to detect recovery of glomerular filtration rate following acute kidney injury. Biomed Res Int 2014;2014:542069.
7.
Bjornsson TD: Use of serum creatinine concentrations to determine renal function. Clin Pharmacokinet 1979;4:200-222.
8.
Rodrigo E, Miñambres E, Ruiz JC, Ballesteros A, Piñera C, Quintanar J, et al: Prediction of delayed graft function by means of a novel web-based calculator: a single-center experience. Am J Transplant 2012;12:240-244.
9.
Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS: Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-172.
10.
Pickering JW, Endre ZH: New metrics for assessing diagnostic potential of candidate biomarkers. Clin J Am Soc Nephrol 2012;7:1355-1364.
11.
Dewitte A, Joannès-Boyau O, Sidobre C, Fleureau C, Bats ML, Derache P, et al: Kinetic eGFR and novel AKI biomarkers to predict renal recovery. Clin J Am Soc Nephrol 2015;10:1900-1910.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.